Wu M - Search Results

1

Characterization, activity, and computer modeling of a molecular inclusion complex containing rifaldazine.

Tan Q, He D, Wu M, Yang L, Ren Y, Liu J, Zhang J. Tan Q, et al. Among authors: wu m. Int J Nanomedicine. 2013;8:477-84. doi: 10.2147/IJN.S38937. Epub 2013 Feb 1. Int J Nanomedicine. 2013. PMID: 23390365 Free PMC article.

2

Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailability.

Tan Q, Liu S, Chen X, Wu M, Wang H, Yin H, He D, Xiong H, Zhang J. Tan Q, et al. Among authors: wu m. AAPS PharmSciTech. 2012 Jun;13(2):534-47. doi: 10.1208/s12249-012-9772-9. Epub 2012 Mar 28. AAPS PharmSciTech. 2012. PMID: 22454136 Free PMC article.

3

Smart Stimuli-Responsive and Mitochondria Targeting Delivery in Cancer Therapy.

Huang Y, Wang T, Tan Q, He D, Wu M, Fan J, Yang J, Zhong C, Li K, Zhang J. Huang Y, et al. Among authors: wu m. Int J Nanomedicine. 2021 Jun 15;16:4117-4146. doi: 10.2147/IJN.S315368. eCollection 2021. Int J Nanomedicine. 2021. PMID: 34163163 Free PMC article. Review.

4

Ternary supramolecular nanocomplexes for superior anticancer efficacy of natural medicines.

Yang J, Fang C, Liu H, Wu M, Tao S, Tan Q, Chen Y, Wang T, Li K, Zhong C, Zhang J. Yang J, et al. Among authors: wu m. Nanoscale. 2021 Sep 17;13(35):15085-15099. doi: 10.1039/d1nr02791c. Nanoscale. 2021. PMID: 34533154

5

Improved pharmacokinetic characteristics and bioactive effects of anticancer enzyme delivery systems.

Yan S, Yang L, Lu L, Guo Q, Hu X, Yuan Y, Li Y, Wu M, Zhang J. Yan S, et al. Among authors: wu m. Expert Opin Drug Metab Toxicol. 2018 Sep;14(9):951-960. doi: 10.1080/17425255.2018.1505863. Epub 2018 Aug 6. Expert Opin Drug Metab Toxicol. 2018. PMID: 30058385 Review.

6

Polydatin protects against lipopolysaccharide-induced fulminant hepatic failure in D-galactosamine-sensitized mice.

Wu MJ, Gong X, Jiang R, Zhang L, Li XH, Wan JY. Wu MJ, et al. Int J Immunopathol Pharmacol. 2012 Oct-Dec;25(4):923-34. doi: 10.1177/039463201202500410. Int J Immunopathol Pharmacol. 2012. PMID: 23298483 Free article.

7

Proteomic analysis for the impact of hypercholesterolemia on expressions of hepatic drug transporters and metabolizing enzymes.

Liu Y, Pu QH, Wu MJ, Yu C. Liu Y, et al. Xenobiotica. 2016 Oct;46(10):940-7. doi: 10.3109/00498254.2016.1144228. Epub 2016 Feb 18. Xenobiotica. 2016. PMID: 26887802

8

Quantitative Proteomic Analysis of Escherichia coli Heat-Labile Toxin B Subunit (LTB) with Enterovirus 71 (EV71) Subunit VP1.

Liu L, Ma Y, Zhou H, Wu M. Liu L, et al. Among authors: wu m. Int J Mol Sci. 2016 Aug 27;17(9):1419. doi: 10.3390/ijms17091419. Int J Mol Sci. 2016. PMID: 27618897 Free PMC article.

9

Proteomic analysis of bladder cancer indicates Prx-I as a key molecule in BI-TK/GCV treatment system.

Jiang L, Xiao X, Ren J, Tang Y, Weng H, Yang Q, Wu M, Tang W. Jiang L, et al. Among authors: wu m. PLoS One. 2014 Jun 6;9(6):e98764. doi: 10.1371/journal.pone.0098764. eCollection 2014. PLoS One. 2014. PMID: 24904997 Free PMC article.

10

iTRAQ‑based quantitative proteomics analysis of the potential application of secretoneurin gene therapy for cardiac hypertrophy induced by DL‑isoproterenol hydrochloride in mice.

Chen H, Wu M, Jiang W, Liu X, Zhang J, Yu C. Chen H, et al. Among authors: wu m. Int J Mol Med. 2020 Mar;45(3):793-804. doi: 10.3892/ijmm.2020.4472. Epub 2020 Jan 22. Int J Mol Med. 2020. PMID: 31985029 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27,825 results

Search Page

Filters